Stock Groups

U.S. CDC recommends five-month gap for Pfizer COVID-19 booster dose -Breaking

by Mike Robinson

[ad_1]

3/3
© Reuters. As Omicron Coronavirus continues its spread in New York City’s Manhattan borough, U.S.A, December 31, 2021, a sign urging vaccinations can be seen at Times Square. REUTERS/Hannah Beier

2/3

(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC), Tuesday suggested reducing the time between Pfizer BioNTech’s second COVID-19 vaccination dose and booster shot from six months to five. 

Following Monday’s U.S. Food and Drug Administration decision to lower the duration of the booster dose and allow the administration of a third dose Pfizer BioNTech vaccine for children between 12 and 15 years, the move was made.

The CDC also recommends that severely or moderately immunocompromised children between the ages of 5 and 11 years get an additional shot 28 days following their first dose.

Pfizer BioNTech’s vaccine is now available to children between five and 11 years of age in the United States.

The CDC has not changed the booster interval recommendation for people who have received the Johnson & Johnson (NYSE:) or the Moderna (NASDAQ:) Vaccine, currently at 2 and 6 months.

On Wednesday, a CDC advisory panel will meet to discuss booster Pfizer BioNTech COVID-19 vaccinations for children 12-15 years old.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]